Vaccines, blood, antisera, toxins and cultures in   Austria

Exports In 2022, Austria exported $6.76B in Vaccines, blood, antisera, toxins and cultures, making it the 11th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 3rd most exported product in Austria. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Austria are: Germany ($1.82B), United States ($1.13B), Poland ($721M), Italy ($428M), and France ($332M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Austria between 2021 and 2022 were United States ($236M), France ($148M), and Switzerland ($72M).

Imports In 2022, Austria imported $5.04B in Vaccines, blood, antisera, toxins and cultures, becoming the 14th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most imported product in Austria. Austria imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($1.52B), Germany ($1.01B), Switzerland ($549M), Italy ($443M), and France ($343M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Austria between 2021 and 2022 were Sweden ($230M), United States ($122M), and Belgium ($84.5M).